Catheter Ablation News and Research

RSS

Experts recommend shortening the blanking period after atrial fibrillation ablation

New evidence-based research calls into question the conventional three-month blanking period immediately after atrial fibrillation (AF) ablation, when early occurrences of AF are thought not to predict long-term AF recurrence.

17 Apr 2024

Exploring the clinical significance of Im-Recurr in patients with atrial fibrillation after ablation

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Immediate recurrence (Im-Recurr), a type of atrial fibrillation (AF) recurrence occurring during the blanking period after radiofrequency catheter ablation (RFCA), has received little attention.

15 Apr 2024

Treating gum disease during AFib blanking period could reduce recurrence risk

Study evaluates whether treating periodontitis during the blanking period after atrial fibrillation (AF) ablation reduces AF recurrence, revealing that comprehensive periodontal care may significantly diminish recurrence rates by addressing inflammation linked to periodontitis.

12 Apr 2024

Periodontal treatment after heart rhythm ablation may reduce AFib recurrence

Treating gum disease in the 3-months after a procedure to correct an irregular heartbeat known as atrial fibrillation (AFib) may lower oral inflammation and may reduce AFib recurrence, according to new research published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.

10 Apr 2024

EHRA 2024 explores prevention and treatment of heart rhythm disorders

Discover the hottest science in the prevention and treatment of heart rhythm disorders at EHRA 2024, a scientific congress of the European Society of Cardiology (ESC).

15 Mar 2024

Comprehensive insights on pathophysiology and clinical management of atrial fibrillation

Atrial fibrillation (AF) is a major global health concern impacting millions and causing symptoms like palpitations, dyspnea, fatigue, dizziness, and chest discomfort.

8 Jan 2024

Cryoablation induces systemic metabolic changes in patients with paroxysmal atrial fibrillation

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Cryoablation (CRYO) is a novel catheter ablation technique for atrial fibrillation (AF).

5 Jan 2024

Smartwatches help physicians to diagnose arrhythmias in children

Smartwatches can help physicians detect and diagnose irregular heart rhythms in children, according to a new study from the Stanford School of Medicine.

13 Dec 2023

New guideline emphasizes prevention, early rhythm control for atrial fibrillation

The American College of Cardiology (ACC) and the American Heart Association (AHA), along with several other leading medical associations, have issued a new guideline for preventing and optimally managing atrial fibrillation (AFib).

30 Nov 2023

Pulsed field ablation safe and effective for women with atrial fibrillation

Women with atrial fibrillation (AF) undergoing a procedure called pulsed field ablation (PFA) have just as good outcomes as men with AF undergoing the same procedure, according to a large-scale international study led by the Icahn School of Medicine at Mount Sinai.

1 Nov 2023

American College of Cardiology releases workbook on home-based cardiac care

The health care landscape has undergone rapid changes in recent years, requiring clinicians and stakeholders to consider innovative ways to provide care in traditional and non-traditional settings.

26 Sep 2023

Pulsed field ablation safe, effective for the treatment of paroxysmal atrial fibrillation

Pulsed field ablation (PFA) is as effective and safe as conventional thermal ablation for the treatment of paroxysmal atrial fibrillation (AF), according to late breaking research presented in a Hot Line session today at ESC Congress 2023.

28 Aug 2023

Ablation more effective than medical therapy in patients with end-stage heart failure, study shows

Atrial fibrillation ablation is associated with lower rates of death, urgent heart transplantation or left ventricular assist device (LVAD) implantation compared with medical therapy in patients with end-stage heart failure, according to late breaking research presented in a Hot Line session today at ESC Congress 2023.

28 Aug 2023

Catheter ablation linked to lower risk of dementia in all patients with atrial fibrillation

Previous studies have shown a link between catheter ablation and a lower risk of dementia and premature death for patients with atrial fibrillation.

23 Aug 2023

Catheter ablation: A new first-line treatment option for atrial fibrillation

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Atrial fibrillation is the most common arrhythmia worldwide, affecting millions of the general population.

20 Jul 2023

Heart Foundation-funded research aims to better treat life-threatening arrhythmias

New research funded by the Heart Foundation aims to boost surgery success rates for life-threatening heart rhythm disorders (arrhythmias), leading to fewer Australians needing defibrillators installed in their chests.

10 Jun 2023

New device makes a heart procedure safer for patients with atrial fibrillation

A new device invented with the help of an electrophysiologist at The Ohio State University Wexner Medical Center makes a heart procedure safer for patients suffering from atrial fibrillation (AFib), a common irregular heart rhythm.

22 May 2023

Novel score identifies the heart failure patients who benefit most from atrial fibrillation ablation

A score based on four readily available clinical and imaging parameters identifies the heart failure patients who benefit most from atrial fibrillation ablation, according to late-breaking science presented at EHRA 2023, a scientific congress of the European Society of Cardiology.

18 Apr 2023

Innovative three-step ablation approach holds promise for patients with persistent atrial fibrillation

An innovative three-step ablation approach including ethanol infusion of the vein of Marshall improves freedom from arrhythmias in patients with persistent atrial fibrillation compared to pulmonary vein isolation (PVI) alone, according to late-breaking science presented at EHRA 2023, a scientific congress of the European Society of Cardiology.